Tikun Olam specializes in breeding proprietary cannabis strains and developing standardized, accurately dosed products. The companys production techniques are focused on increasing the efficacy of the plants active ingredients. Tikun Olams products are used in a number of ongoing clinical trials in Israels regulated medical cannabis market. Tikun Olam also operates Tikun Olam Care, a professional cannabis nursing clinic that provides safe and personalized treatment for a variety of medical conditions to more than 20,000 patients of all ages. In early 2020, Cannbit Pharmaceuticals acquired Tikun Olam for $23 million, in addition to 5% of the its shares and other amounts based on the companys success.